Navigo Proteins GmbH

Navigo Proteins discovers and develops novel scaffold proteins-based affinity ligands for commercial biologics GMP purification or as biopharmaceutical drugs/binders. They are all small, stable, highly engineerable, selective, and economically, homogeneously producible. In PRECISION CAPTURING a protein A-like scaffold serves for an antibody-like capture step even of non-Fc bearing molecules. In PRECISION TARGETING human ubiquitin is the basis for highly selective Affilin ligands as part of a broad range of biopharmaceutical drugs. Navigo Proteins unique protein engineering expertise is the basis a world-wide unique, versatile scaffold proteins platform. Our robust, rapid and reliable high-throughput-based, robotics assisted platform designs, produces, analyzes and...

Protein engineering,affinity chromatography,downstream processing,protein-drug-conjugates,target specific delivery,and radiopharmaceuticals

Navigo proteins gmbh operates in the Biotechnology research industry.

Navigo proteins gmbh's revenue is 11m - 100m

Navigo proteins gmbh has 11 - 50 employees.